At Lovelace Biomedical, our mission is to deeply understand every client’s goals and design unique research programs that advance novel therapies into clinical testing. We thrive on solving complex challenges, but we give the same level of rigor and attention to seemingly straightforward studies that are just as critical to regulatory success.

About Us

Lovelace Biomedical is a not-for-profit contract research organization with a rich history of helping its pharmaceutical and biotechnology partners achieve great things.

Over nearly seven decades, we have built a reputation for leveraging a multidisciplinary toolset to push the limits of preclinical research — all while offering a streamlined customer experience, with fast, direct and personal access to our industry-leading scientific experts.

Our common-sense organizational structure enables quick turnaround on proposals and contracts, and the ability to adapt our business process to our clients’ unique research needs.

Located on an expansive bio-secure facility in beautiful Albuquerque, New Mexico, we are equipped to handle just about any preclinical program, from investigational gene therapies to infectious disease solutions. We work hard to understand your goals — and get you to where you need to be.

Importantly, as a not-for-profit research institute, we are beholden to science — and not shareholders. We invest generously in basic science and cutting-edge technologies so that we can help you accomplish your research objectives, no matter how complex.



Lovelace Family of Companies & Partners

Lovelace Biomedical, a commercially-focused entity dedicated to contract research, is affiliated with a family of companies that provide a unique depth of expertise in nonclinical and clinical research. Fellow Lovelace companies and our partners include:

Lovelace Respiratory Research Institute

Lovelace Respiratory Research Institute (LRRI) is a private biomedical research organization dedicated to improving public health through research on respiratory disease; biodefense countermeasures; environmental toxicology and human health; and mental illness and brain disorders. The Institute readily opens its unique research facilities to external collaborators who are in pursuit of discovering new therapies and preventive treatments to disease.

Mind Research Network

The Mind Research Network is dedicated to the discovery and advancement of clinical solutions for the prevention, diagnosis and treatment of mental illness and other brain disorders. MRN consists of an interdisciplinary association of scientists located at universities, national laboratories and research centers around the world and is focused on imaging technology and its emergence as an integral element of neuroscience investigation.

Lovelace Scientific Resources

Lovelace Scientific Resources (LSR) is an independent clinical trials company that maintains centralized services and collaborates with our network of clinical trial sites throughout the United States. With the participation of study volunteers, LSR works to evaluate the safety and effectiveness of new medical treatments, drugs and devices.

LSR is also home to LSR Diagnostics who, in partnership with Mako Medical, provides CLIA certified diagnostic testing.

Salzman Group

The Salzman Group is a boutique contract service organization that advances clients’ drug development projects towards clinical proof of concept.  Andrew L. Salzman, M.D. serves as Lovelace’s Director of Translational Science.

Our History

It all started in 1947

That’s when Dr. William Randolph “Randy” Lovelace II, an acclaimed surgeon and Harvard medical graduate, established a much-needed specialty medicine clinic and nonprofit medical foundation in Albuquerque, New Mexico.

Originally known as the Lovelace Foundation for Medical Education and Research, Lovelace Biomedical stands today as one of the nation’s largest independent, not-for-profit organization conducting basic and applied research to advance novel therapeutics into the clinic and beyond.

Over the years, the organization’s research operations expanded in size, scope and recognition—very much in parallel with the advances of the medical and health care industry overall. Initially funded predominantly by government contracts to execute cutting-edge projects related to public health, Lovelace Biomedical has became known as a place of medical firsts and continues to build on that legacy today.


Aviation Medicine and NASA

With a strong tie to the aviation community starting from its earliest days, Lovelace Biomedical became known in the 1950s and ’60s as the nation’s premier center for aviation and space medicine research. Physiological studies of commercial and military pilots led to an Air Force grant to develop a protocol for testing candidates for space flight. In 1959, under contract to the newly formed NASA, Lovelace tested 32 candidate pilots using a seven-day series of rigorous physiological and psychological tests, culminating in selection of the seven Project Mercury astronauts.

A follow-up project demonstrated that women could pass the tests with approximately the same success rate as men, leading to the immediate inclusion of women in the Russian space program. (The first U.S. woman flew into space 20 years later.) Dr. Lovelace was appointed by President Johnson as Director of Space Medicine for NASA in 1964.


Respiratory Research

Lovelace Biomedical’s specialized work in the area of aerosol science far exceeds any other contract research organization. It was the first company to demonstrate that cigarette smoking causes cancer in laboratory animals—a discovery that ultimately led to greater public awareness of the dangers of smoking.

In the area of aerosol science, the in-house R&D team has developed a range of innovative measurement instruments such as the Lovelace multijet impactor, the Lovelace nebulizer for optimal delivery of fine particles, the Lovelace aerosol particle separator, aerosol dose delivery techniques for all research species and a parallel plate diffusion battery measuring particle size in aerosols.

Today, Lovelace Biomedical’s respiratory research activities include major programs in fundamental lung biology, lung cancer detection and prevention, asthma, chronic obstructive pulmonary disease, environmental inhalation hazards and more.


Animal Physiology

Lovelace Biomedical has pioneered the development of new biomedical measurement techniques for a variety of species. From tools that mimic human pulmonary maneuvers, to the first successful lung transplant in dogs, Lovelace has proven time and again that it can create solutions that meet the physiological measurement needs at hand, regardless of how complex the challenge is. As a not-for-profit, Lovelace is not beholden to shareholders, and continually devotes significant resources to R&D to develop new measurement technologies.



Lovelace Biomedical’s expansive campus, with military-grade security, enables us to carry out sensitive projects that cannot be conducted in smaller or urban-based environments. Our state-of-the-art facilities are centralized on a company-owned site within a U.S. Air Force base in Albuquerque, New Mexico.

Animal Housing

With more than 100 acres of land and 300,000 square feet of laboratory space, Lovelace Biomedical has one of the most extensive animal housing areas available among domestic preclinical research organizations — including unlimited space for expansion into new animal housing or experimental facilities. In addition to surgical suites and more than 90 animal rooms, our specialized on-site laboratories provide capabilities in histopathology, clinical pathology, analytical and bioanalytical chemistry, microbiology, virology, and cell and molecular biology.

High-Containment Facility

Lovelace Biomedical has over 10,000 square feet of ABSL3-enhanced laboratory space, with six multi-species animal rooms capable of housing rodents, rabbits, ferrets and non-human primates.  The high-containment labs are fully GLP compliant with remote telemetry capabilities, two aerosol exposure laboratories, a state-of-the art necropsy suite with full hematology and clinical chemistry analysis capabilities, as well as fully equipped microbiology and virology laboratories.

GLP Regulations

Lovelace Biomedical’s operations are fully compliant with the FDA’s Good Laboratory Practice regulations (21 CFR Part 58) and other customer requirements, and have onsite Quality Assurance teams that are engaged in all GLP studies.

Humane Care Commitment

Lovelace Biomedical is devoted to the humane and ethical treatment of all animals involved in research. Our dedicated behavioral management staff works with subject matter experts in the field to share best practices in enrichment and environmental enhancement for research animals.

Our approach to animal treatment, which includes positive reinforcement training and specialty food enrichment prepared in our food-grade enrichment kitchen, provides for the psychological well-being and comfort of animals, thus reducing stress and increasing safety. We provide opportunities for animals to express species-specific behavior, such as gnawing, burrowing, foraging, playing, scratching, exploring and exercising.

Finally, our husbandry and enrichment staff have designed and developed enrichment programs and devices for a number of species we work with. We are proud of this creative participation in providing thoughtful enrichment for the animals they care for.

Accreditations and Licenses

Lovelace has been accredited with the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) since 1970 demonstrating our commitment to responsible animal care and use. AAALAC works with institutions and researchers to serve as a bridge between progress in biomedical research and animal well-being. This is done through AAALAC’s voluntary accreditation process in which research programs demonstrate that they meet the minimum standards required by law, and are also going the extra step to achieve excellence in animal care and use. In this way, AAALAC International is where science and responsible animal care connect.

The Office of Laboratory Animal Welfare (OLAW) issued the renewal of our Animal Welfare Assurance, demonstrating our continued compliance with Public Health Service Policy on Humane Care and Use of Laboratory Animals. OLAW provides guidance and interpretation of the Public Health Service (PHS) Policy on Humane Care and Use of Laboratory Animals, supports educational programs, and monitors compliance with the Policy by Assured institutions and PHS funding components to ensure the humane care and use of animals in PHS-supported research, testing, and training, thereby contributing to the quality of PHS-supported activities.

Lovelace is registered and certified with the United States Department of Agriculture (USDA) as a Class R Research Facility, upholding compliance to the Animal Welfare Act. The Animal Welfare Act and its associated regulations require that federally established standards of care and treatment be provided for animals used in research.